Mission
Our mission is to work with biomolecular researchers/neuroscientists, commercial biotech and pharmacological companies, and constituents in the brain injury community to catalyze biomolecular and biotechnological methods of regenerating the moderately and severely injured brain. By doing so, we believe the quality of life for individuals in the chronic phase of living with a serious brain injury (and the quality of life of their families) can be substantially improved.